Showing results (21-30 of 34) with videos related to
Sort By:
Pageof 4
Frontiers in Cell and Developmental Biology|December 13, 2021
Epithelial-Mesenchymal Transition Induces GSDME Transcriptional Activation for Inflammatory PyroptosisChenqiang Jia, Zhuqing Zhang, Jun Tang, et al.The Journal of Urology|June 1, 2021
Urinary Molecular Pathology for Patients with Newly Diagnosed Urothelial Bladder CancerRuiyun Zhang, Jingyu Zang, Feng Xie, et al.British Journal of Cancer|March 30, 2023
APOBEC3B stratifies ovarian clear cell carcinoma with distinct immunophenotype and prognosisXiaoran Long, Huaiwu Lu, Mei-Chun Cai, et al.Cell Death and Differentiation|September 28, 2022
Transient targeting of BIM-dependent adaptive MCL1 preservation enhances tumor response to molecular therapeutics in non-small cell lung cancerKaixuan Shi, Haijiao Lu, Zhenfeng Zhang, et al.British Journal of Cancer|October 22, 2020
Baseline immunity and impact of chemotherapy on immune microenvironment in cervical cancerYi Zhang, Minhua Yu, Ying Jing, et al.Cancer Research|July 20, 2022
Dual Inhibition of CDK12/CDK13 Targets Both Tumor and Immune Cells in Ovarian CancerLin Cheng, Shichao Zhou, Shaoqing Zhou, et al.Oncogene|January 9, 2019
Hybrid sequencing-based personal full-length transcriptomic analysis implicates proteostatic stress in metastatic ovarian cancerYing Jing, Yi Zhang, Hui Zhu, et al.Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|September 3, 2024
Genomic Profiling and Immune Phenotyping of Neuroendocrine Bladder CancerJingyu Zang, Akezhouli Shahatiaili, Mei-Chun Cai, et al.Nature Communications|October 12, 2017
Simultaneous evolutionary expansion and constraint of genomic heterogeneity in multifocal lung cancerPengfei Ma, Yujie Fu, Mei-Chun Cai, et al.Cell Death & Disease|November 28, 2024
YY1 downregulation underlies therapeutic response to molecular targeted agentsShichao Zhou, Jingyu Zang, Mei-Chun Cai, et al.Pageof 4